Slovakia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Slovakia

The Slovak prophylactic medicaments containing insulin market reached $X in 2022, approximately reflecting the previous year. The market value increased at an average annual rate of +2.7% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the market attained the maximum level at $X in 2018; however, from 2019 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Slovakia

In value terms, prophylactic medicaments containing insulin production stood at $X in 2022 estimated in export price. The total output value increased at an average annual rate of +2.0% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2014 with an increase of 26% against the previous year. As a result, production reached the peak level of $X. From 2015 to 2022, production growth remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Slovakia

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported from Slovakia fell rapidly to X tons, with a decrease of -35.7% against 2021 figures. In general, exports, however, enjoyed a significant increase. The most prominent rate of growth was recorded in 2014 with an increase of 379% against the previous year. Over the period under review, the exports hit record highs at X tons in 2016; however, from 2017 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports shrank markedly to $X in 2022. Overall, exports, however, continue to indicate a resilient increase. The most prominent rate of growth was recorded in 2015 with an increase of 193%. The exports peaked at $X in 2016; however, from 2017 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

The Czech Republic (X tons) was the main destination for prophylactic medicaments containing insulin exports from Slovakia, accounting for a 80% share of total exports. Moreover, prophylactic medicaments containing insulin exports to the Czech Republic exceeded the volume sent to the second major destination, Germany (X kg), eightfold. The third position in this ranking was held by the Netherlands (X kg), with a 5.9% share.

From 2012 to 2022, the average annual growth rate of volume to the Czech Republic totaled +42.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (+3.6% per year) and the Netherlands (+6.4% per year).

In value terms, the Czech Republic ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Slovakia, comprising 73% of total exports. The second position in the ranking was taken by Germany ($X), with a 9.8% share of total exports. It was followed by the Netherlands, with a 7.4% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the Czech Republic totaled +29.6%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (+6.0% per year) and the Netherlands (-2.0% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per kg in 2022, increasing by 18% against the previous year. In general, the export price, however, recorded a noticeable shrinkage. The pace of growth appeared the most rapid in 2013 when the average export price increased by 242% against the previous year. As a result, the export price attained the peak level of $X per kg. From 2014 to 2022, the average export prices remained at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Ireland ($X per kg), while the average price for exports to the Czech Republic ($X per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Bulgaria (+36.8%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Slovakia

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses increased by 9.8% to X tons, rising for the second consecutive year after two years of decline. The total import volume increased at an average annual rate of +1.4% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2018 when imports increased by 45% against the previous year. As a result, imports attained the peak of X tons. From 2019 to 2022, the growth of imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports contracted significantly to $X in 2022. The total import value increased at an average annual rate of +1.2% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2013 when imports increased by 39% against the previous year. Imports peaked at $X in 2019; however, from 2020 to 2022, imports failed to regain momentum.

Imports by Country

France (X tons), Germany (X tons) and Italy (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Slovakia, with a combined 72% share of total imports. Denmark, Malaysia, Brazil and the United States lagged somewhat behind, together comprising a further 25%.

From 2012 to 2022, the biggest increases were recorded for Malaysia (with a CAGR of +49.7%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Slovakia were France ($X), Germany ($X) and Italy ($X), with a combined 66% share of total imports.

Among the main suppliers, Italy, with a CAGR of +48.7%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, waning by -32.9% against the previous year. In general, the import price saw a relatively flat trend pattern. The pace of growth appeared the most rapid in 2019 when the average import price increased by 26% against the previous year. The import price peaked at $X per ton in 2014; however, from 2015 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Brazil ($X per ton), while the price for Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Germany (+9.4%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :